These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9487272)

  • 1. Towards a better yardstick: the choice of treatment thresholds in hypertension.
    McAlister FA; Laupacis A
    Can J Cardiol; 1998 Jan; 14(1):47-51. PubMed ID: 9487272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of severe arterial hypertension: cost of drug prescriptions in accordance with ANAES guidelines].
    Fender P; Guilhot J; Tilly B; Salanave B; Allemand H
    Therapie; 2001; 56(2):111-8. PubMed ID: 11471361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of hypertension guidelines in South Africa: absolute risk versus blood pressure level.
    Gaziano TA; Steyn K; Cohen DJ; Weinstein MC; Opie LH
    Circulation; 2005 Dec; 112(23):3569-76. PubMed ID: 16330698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An economic evaluation of the 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of mild-to-moderate hypertension in Greece.
    Stafilas PC; Sarafidis PA; Lasaridis AN; Aletras VH; Niakas DA
    Am J Hypertens; 2005 Sep; 18(9 Pt 1):1233-40; discussion 1241-2. PubMed ID: 16182115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How willing are the public to pay for anti-hypertensive drugs for primary prevention of cardiovascular disease: a survey in a Chinese city.
    Tang JL; Wang WZ; An JG; Hu YH; Cheng SH; Griffiths S
    Int J Epidemiol; 2010 Feb; 39(1):244-54. PubMed ID: 19491141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypertension management in general practice in Iceland].
    Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
    Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are current strategies for treating hypertension effective?
    Sica DA
    J Clin Hypertens (Greenwich); 2003; 5(3 Suppl 2):23-32. PubMed ID: 12826767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of severe hypertension in France in 1999 and 2000: intermediate results of a health insurance intervention program].
    Tilly B; Guilhot J; Salanave B; Fender P; Allemand H
    Arch Mal Coeur Vaiss; 2002; 95(7-8):687-94. PubMed ID: 12365081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of French guidelines in newly diagnosed hypertensive patients managed by general practitioners].
    Hanon O; Hoguin JC; Girerd X
    Arch Mal Coeur Vaiss; 2003; 96(7-8):744-7. PubMed ID: 12945215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Are the 1999 World Health Organization-International Society of Hypertension recommendations applicable to clinical practice?].
    Hanon O; Anagnostopoulos K; Franconi G; Amah G; Safar M; Girerd X
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):953-7. PubMed ID: 10989736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical relevance of pharmacological blood pressure lowering mechanisms.
    Lonn E
    Can J Cardiol; 2004 Aug; 20 Suppl B():83B-88B. PubMed ID: 15309210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward targeted hypertension screening guidelines.
    van Buuren S; Boshuizen HC; Reijneveld SA
    Med Decis Making; 2006; 26(2):145-53. PubMed ID: 16525168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New treatment guidelines for a patient with diabetes and hypertension.
    Mogensen CE
    J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hypertension in Finnish general practice seems unsatisfactory despite evidence-based guidelines.
    Varis J; Savola H; Vesalainen R; Kantola I
    Blood Press; 2009; 18(1-2):62-7. PubMed ID: 19353413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and treatment of severe asymptomatic hypertension.
    Kessler CS; Joudeh Y
    Am Fam Physician; 2010 Feb; 81(4):470-6. PubMed ID: 20148501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thiazides--a first choice against high blood pressure].
    Meland E
    Tidsskr Nor Laegeforen; 2009 Sep; 129(18):1876-7. PubMed ID: 19844281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 2000 Canadian recommendations for the management of hypertension: Part one--therapy.
    McAlister FA; Levine M; Zarnke KB; Campbell N; Lewanczuk R; Leenen F; Rabkin S; Wright JM; Stone J; Feldman RD; Lebel M; Honos G; Fodor G; Burgess E; Tobe S; Hamet P; Herman R; Irvine J; Culleton B; Petrella R; Touyz R;
    Can J Cardiol; 2001 May; 17(5):543-59. PubMed ID: 11381277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.